IRIS
POLONI, Antonella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.433
EU - Europa 3.631
AS - Asia 1.356
AF - Africa 133
SA - Sud America 20
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 6
Totale 11.598
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.423
IT - Italia 817
UA - Ucraina 774
IE - Irlanda 473
SG - Singapore 464
SE - Svezia 412
DE - Germania 362
CN - Cina 341
TR - Turchia 300
DK - Danimarca 288
FI - Finlandia 204
KR - Corea 158
GB - Regno Unito 115
FR - Francia 109
CI - Costa d'Avorio 80
IN - India 57
MA - Marocco 47
BE - Belgio 22
BR - Brasile 19
EU - Europa 19
JP - Giappone 12
PL - Polonia 10
RU - Federazione Russa 10
AT - Austria 8
CA - Canada 7
HK - Hong Kong 6
AU - Australia 5
CH - Svizzera 5
NL - Olanda 5
CZ - Repubblica Ceca 4
ES - Italia 4
BZ - Belize 3
IR - Iran 3
TN - Tunisia 3
BD - Bangladesh 2
BG - Bulgaria 2
IL - Israele 2
MT - Malta 2
PH - Filippine 2
PT - Portogallo 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BJ - Benin 1
ET - Etiopia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MC - Monaco 1
MN - Mongolia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PK - Pakistan 1
TM - Turkmenistan 1
UZ - Uzbekistan 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 11.598
Salva come PNG Salva come JPEG
Città #
Jacksonville 820
Chandler 752
Fairfield 619
Dublin 473
Boardman 461
Ashburn 374
Des Moines 336
Wilmington 325
New York 242
Houston 232
Seattle 231
Singapore 213
Woodbridge 209
Lawrence 182
Princeton 182
San Mateo 176
Cambridge 147
Ann Arbor 129
Centro 112
Abidjan 80
San Diego 78
Redmond 74
Turin 64
Beijing 62
Helsinki 50
Marche 46
Milan 40
Pune 39
Ancona 34
Guangzhou 34
Porto 33
Shanghai 33
Norwalk 27
Pianella 27
Los Angeles 25
London 24
Washington 22
Brussels 19
Dallas 14
Falconara Marittima 14
Wuhan 14
Rome 13
Hangzhou 12
Wuxi 12
San Benedetto del Tronto 11
Kilburn 9
Tolentino 9
Acerra 8
Philadelphia 8
Prescot 8
Shenzhen 8
Venice 8
Vienna 8
Florence 7
Pavia 7
Andria 6
Hyderabad 6
Southwark 6
Fayetteville 5
Hong Kong 5
Istanbul 5
Jiaxing 5
Jinhua 5
Leeds 5
Osimo 5
Torino 5
Auburn Hills 4
Castelnuovo Rangone 4
Chiaravalle 4
Chiswick 4
Falls Church 4
Heze 4
Hounslow 4
Izmir 4
Jinan 4
Mistretta 4
Mumbai 4
New Bedfont 4
Pistoia 4
Verona 4
Bologna 3
Civitanova Marche 3
Delhi 3
Kagoya 3
Lincoln 3
Monza 3
Munich 3
Naples 3
Olomouc 3
Ottawa 3
Palermo 3
Palo Alto 3
Paris 3
Parma 3
Pescara 3
Redwood City 3
San Benedetto Del Tronto 3
Seoul 3
Terenzano 3
Trieste 3
Totale 7.370
Salva come PNG Salva come JPEG
Nome #
Algoritmi diagnostico-terapeutici in Ematologia 248
Human white adipocytes convert into “rainbow” adipocytes in vitro 192
Serum Inflamma-miR Signature: A Biomarker of Myelodysplastic Syndrome? 154
Human de-differentiated adipocytes show similar properties to bone marrow derived mesenchymal stem cells 138
Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial. 136
Conditioning regimen with beam plus amifostine for outpatient autologous stem cell tansplantation: feasibility and outcome in 97 lymphoma patients. 126
Feasibility and Outcome of a Phase II Study of Intensive Induction Chemotherapy in 91 Elderly Patients with AML Evaluated Using a Simplified Multidimensional Geriatric Assessment 121
Low-dose Gemtuzumab-Ozogamicin as post-consolidation therapy in elderly patients with acute myeloid leukaemia: a pilot study. 114
Glial-like differentiation potential of human mature adipocytes 109
Human bone marrow adipocytes maintain the survival and differentiation of hematopoietic stem cells 103
Azacitidine Treatment in High Risk Myelodysplastic Patients in Complete Haematological Remission Reverts Mesenchymal Stem Cells to a Normal Phenotype 102
High predictive value of the revised international prognostic scoring system (IPSS-R): an external analysis of 646 patients from a multiregional italian MDS registry 101
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease 100
null 100
The exosomal surface phenotype and inflamma-miR cargo correlate with MDS diagnosis 100
Low FasL levels promote proliferation of human bone marrow-derived mesenchymal stem cells, higher levels inhibit their differentiation into adipocytes. 98
Gene expression profile of cytokines in patients with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with reduced conditioning. 98
Plasticity of human dedifferentiated adipocytes toward endothelial cells 95
Thalidomide, dexamethasone, and pegylated liposomal doxorubicin (ThaDD) for patients older than 65 years with newly diagnosed multiple myeloma. 95
Efficacy and feasibility of high-dose cytarabine plus idarubicin and amifostine as induction schedule: a prospective observational study of 100 AML elderly patients 94
The Exaggerated Collagen Expression in Gvhd-Fibroblasts Is Effectively Inhibited By Therapeutic Concentration of Nilotinib 93
Apoptotic mechanism activated by blue light and cisplatinum in cutaneous squamous cell carcinoma cells 93
A real life survey on erytropoietin alpha treatment in a cohort of 1049 low risk MDS patients: an italian MDS registry study 90
Human AB serum for generation of mesenchymal stem cells from human chorionic villi: comparison with other source and other media including platelet lysate 90
Biosafety evidence for human dedifferentiated adipocytes 90
Effects of erythropoiesis-stimulating agents on overall survival of International Prognostic Scoring System Low/Intermediate-1 risk, transfusion-independent myelodysplastic syndrome patients: a cohort study 90
In vitro comparison of different TKI activity in T-Cell populations: selective sparing of Treg by Nilotinib. 88
Mobilization-Driven Postconsolidation Therapy in Elderly Patients with Acute Myeloid Leukemia: Feasibility and Efficacy of Autologous Stem Cell Transplantation versus Low-Dose Gemtuzumab Ozogamicin 87
Immunomodulatory Effects of Tyrosine Kinase Inhibitor In Vitro and In Vivo Study 87
Hematologic reconstitution after PBPC autotransplantation:comparison between programmed-rate freezing and uncontrolled freezing at –80° 86
A Combination of Lenalidomide and Rituximab (ReRi) As Salvage Therapy in Elderly Patients Affected By Diffuse Large B Cells (DLBCL) Lymphoma Relapsed and Refractory 86
Molecular and functional characterization of human bone marrow adipocytes 85
Efficacy and safety of eltrombopag for the treatment of thrombocytopenia of low and intermediate-1 IPSS risk myelodysplastic syndromes: interim analysis of a prospective, randomized, single-blind, placebo-controlled trial (EQoL-MDS) 83
Adipocytes properties and crosstalk with immune system in obesity-related inflammation. 83
Amifostine can reduce mucosal damage after high-dose melphalan conditioning for peripheral blood progenitor cell autotransplant: a retrospective study 82
Tailored Therapy in an Unselected Population of 91 Elderly Patients with DLBCL Prospectively Evaluated Using a Simplified CGA. 82
Bone marrow adipose tissue is a unique adipose subtype with distinct roles in glucose homeostasis 80
Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD 79
Overexpression of CDKN2B (p15INK4B) and altered global DNA methylation status in mesenchymal stem cells of high-risk myelodysplastic syndromes 78
Interaction between human mature adipocytes and lymphocytes induces T-cell proliferation 78
LATE EFFECTS IN Hodgkin's POPULATION Treated BETWEEN 1980-2005 IN A SINGLE INSTITUTION 78
The Time Has Come for Targeted Therapies for AML: Lights and Shadows 78
Iron overload alters the energy metabolism in patients with myelodysplastic syndromes: results from the multicenter FISM BIOFER study 78
Selection of CD271(+) cells and human AB serum allows a large expansion of mesenchymal stromal cells from human bone marrow 77
Prognostic role of immunohistochemical analysis of 5 mc in myelodysplastic syndromes. 77
DNA demethylating therapy reverts mesenchymal stromal cells derived from high risk myelodysplastic patients to a normal phenotype 77
LA POSITIVITÀ DEL WT1 POST-INDUZIONE È UN IMPORTANTE FATTORE PROGNOSTICO PREDITTIVO DI RECIDIVA PRECOCE IN UNA CASISTICA DI 80 PAZIENTI AFFETTI DA LEUCEMIA ACUTA MIELOIDE 77
Human Mesenchymal Stem Cells from chorionic villi and amniotic fluid are not susceptible to transformation after extensive in vitro expansion 77
CHANGES IN RPS14 EXPRESSION LEVELS DURING LENALIDOMIDE TREATMENT IN LOW- AND INTERMEDIATE-1-RISK MYELODYSPLASTIC SYNDROMES WITH CHROMOSOME 5Q DELETION 76
Preventive Effects of Cardotoxicities By Liposomal Anthracyclines non Pegilated in 95 Perspective Patients Affected By Lymphoma and Monitored By Biomarkers and Ecocardiography 75
A new schedule of CHOP/rituximab plus granulocyte-macrophage colony-stimulating factor is an effective rescue for patients with aggressive lymphoma failing autologous stem cell transplantation. 75
Long duration of response to azacitidine in MDS. Multicenter retrospective study of 36 patients 74
Screening of psychological distress in oncology and hematology department at Ospedali Riuniti Ancona 74
Gemtuzumab-Ozogamicin as Post-Consolidation Therapy In Elderly Patients with Acute Myeloid Leukemia: a Pilot Study 73
Emopoiesi normale e mielodisplastica 72
Bone marrow adipocytes support haematopoietic stem cell survival 72
A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia 72
A new intensive induction schedule, including high-dose Idarubicin, high-dose Aracytin and Amifostine, in older AML patients: feasibility and long-term results in 42 patients. 71
Characterization and expansion of mesenchymal progenitor cells from first-trimester chorionic villi of human placenta. 69
History and scientific production of clinica medica and clinica ematologica in ancona 69
Cytokine expression profile of selected cell populations from patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation wih reduced conditioning. 68
Biological activity of lenalidomide in myelodysplastic syndromes with del5q: results of gene expression profiling from a multicenter phase II study 67
Telomere length, c-myc and mad-1 expression could represent prognosis markers of myelodysplastic syndrome 66
Identification of different adypocytes populations within human marrow microenvironment 66
VERY LOW TOXICITY AND GOOD QUALITY OF LIFE IN 48 ELDERLY PATIENTS AUTOTRANSPLANTED FOR HEMATOLOGICAL MALIGNANCIES: A SINGLE CENTER EXPERIENCE 65
Can the revised IPSS predict response to erythropoietic-stimulating agents in patients with classical IPSS low or intermediate-1 MDS? 65
Engraftment capacity of mesenchymal cells following hematopoietic stem cell transplantation in patients receiving reduced-intensity conditioning regimen. 64
Hematologic reconstitution after PBPC autotransplantation: comparison between programmed-rate freezing and uncontrolled-rate freezing at -80 degrees C 64
QUALITY OF LIFE ASSESSMENT IN PATIENTS AFFECTED BY MYELODYSPLASTIC SYNDROME 63
OVEREXPRESSION OF CDKN2B IS ASSOCIATED WITH REDUCED PROLIFERATIVE POTENTIAL IN MESENCHYMAL STEM CELL FROM HIGH-RISK MYELODYSPLASTIC SYNDROME 63
Aging- and Senescence-associated Changes of Mesenchymal Stromal Cells in Myelodysplastic Syndromes 63
Prognostic factors of response to erytropoiesis stimulating agents (ESA) Treatment in non RBC transfusion dependent lower risk MDS. Preliminary results of a french and italian study (on behalf of the GFM and FISM) 62
TREATMENT WITH AZACITIDINE REVERSES MESENCHYMAL STEM CELLS DERIVED FROM HIGH RISK MYELODYSPLASTIC PATIENTS TO A NORMAL PHENOTYPE 61
LENALIDOMIDE FOR THE TREATMENT OF LOW- AND INT-1-RISK MDS WITH DEL(5Q): EFFICACY AND QUALITY OF LIFE STUDY 60
GENE EXPRESSION CHANGES IN BONE MARROW OF MDS PATIENTS WITH DEL(5Q) DURING LENALIDOMIDE TREATMENT 60
AMIFOSTINE CAN REDUCE MUCOSAL DAMAGE AFTER HIGH-DOSE MELPHALANCONDITIONING FOR PERIPHERAL BLOOD PROGENITOR CELL AUTOTRANSPLANT: A RETROSPECTIVE STUDY. EFFECT OF AMIFOSTINE ON MUCOSITIS DURING AUTOLOGOUS PBPC TRANSPLANTATION 60
mTOR and STAT3 Pathway Hyper-Activation is Associated with evated Interleukin-6 Levels in Patients with Shwachman-Diamond Syndrome: Further Evidence of Lymphoid Lineage Impairment 60
Strategie generali di trattamento 59
Combined administration of alpha-erythropoietin and filgrastim can improve the outcome and cost balance of autologous stem cell transplantation in patients with lymphoproliferative disorders. 59
Predictive value of post-induction and post-consolidation MRD: a comparison of multiparameter flow cytometry and WT1 RT-PCR techniques in 75 acute myeloid leukemia (AML) patients 59
Bone Marrow Immunological Changes During Treatment with Lenalidomide In Low and Intermediate-1 Risk Myelodysplastic Syndromes with Del(5Q) 59
P077 Adaptation and changes in quality of life in patients with myelodysplastic syndrome 59
Nilotinib Treatment of Patients Affected by Chronic Graft-versus-Host Disease Reduces Collagen Production and Skin Fibrosis by Downmodulating the TGF-β and p-SMAD Pathway 58
Mesenchymal stem cells of myelodysplastic syndromes show impaired hematopoietic support function and global DNA hypermethylation status 58
ITACA: A new validated international erythropoietic stimulating agent-response score that further refines the predictive power of previous scoring systems 58
Salvage therapy with an outpatient DHAP schedule followed by PBSC transplantation in 79 lymphoma patients: an intention to mobilize and transplant analysis. 58
Bone Marrow "Yellow" and "Red" Adipocytes: Good or Bad Cells? 58
Reporting Guidelines, Review of Methodological Standards, and Challenges Toward Harmonization in Bone Marrow Adiposity Research. Report of the Methodologies Working Group of the International Bone Marrow Adiposity Society 58
Acute promyelocyte leukemia arose from CALR 1 mutated post essential thrombocythemia- myelofibrosis with splanchnic vein thrombosis: A case report 58
A new schedule of CHOP/rituximab plus granulocyte-macrophage colony-stimulating factor is an effective rescue for patients with aggressive lymphoma failing autologous stem cell trasplantation 57
COMPARISON OF CD34+ BONE MARROW CELLS PURIFIED BY IMMUNOMAGNETIC AND IMMUNOADSORPTION CELL SEPARATION TECHNIQUES 57
Post-transplant events Combined administration of alpha-erythropoietin and filgrastim can improve the outcome and cost balance of autologous stem cell transplantation in patients with lymphoproliferative disorders 56
EX VIVO PHARMACOLOGICAL PURGING OF LEUKAPHERESIS COLLECTIONS WITH NITROGEN MUSTARD: AMIFOSTINE PRETREATMENT IMPROVES BOTH EARLY AND LATE PERIPHERAL BLOOD PROGENITOR CELL RECOVERY 55
FLT 3 LIGAND, MGDF, EPO AND G-CSF ENHANCE EX VIVO EXPANSION OF HEMATOPOIETIC CELL COMPARTMENTS IN THE PRESENCE OF SCF, IL-3 AND IL-6 55
A Real Life Survey On Erythropoietin Alpha Treatment In a Cohort Of 1049 Low Risk MDS Patients: An Italian MDS Registry Study 55
Randomised Long Term Effects of Eltrombopag Treatment Versus Placebo for Low-Risk Myelodysplastic Syndromes with Thrombocytopenia (EQoL-MDS): Interim Results of a Single-Blind, Randomised, Controlled, Phase 2 Superiority Trial 55
PBSC collection after high dose chemotherapy followed by G-CSF in patients with malignancies: analysis of results regarding factors affecting the yield of hemopoietic progenitors. 54
Specific molecular signatures predict decitabine response in chronic myelomonocytic leukemia 54
P112 Gene expression patterns in MDS with del5q before and during lenalidomide treatment 54
Clinical Relevance of Individual Response to Iron Chelation Therapy (ICT) in Patients with Myelodysplastic Syndromes (MDS) and Transfusion Requirement 54
Totale 8.009
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.220
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.220
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020633 0 0 0 0 0 1 159 4 160 22 72 215
2020/20212.558 100 235 344 48 354 217 266 117 313 177 263 124
2021/20221.467 72 351 26 90 10 80 68 111 91 131 136 301
2022/20232.479 225 241 208 188 155 516 2 120 584 10 184 46
2023/20241.626 228 49 87 233 254 371 42 35 5 56 33 233
2024/20251.119 363 324 142 63 135 92 0 0 0 0 0 0
Totale 12.049